Airway gene transfer in a non-human primate: Lentiviral gene expression in marmoset lungs

Files

hdl_78539.pdf (553.42 KB)
  (Published version)

Date

2013

Authors

Farrow, N.
Miller, D.
Cmielewski, P.
Donnelley, M.
Bright, R.
Parsons, D.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Scientific Reports, 2013; 3(1):1-3

Statement of Responsibility

N. Farrow, D. Miller, P. Cmielewski, M. Donnelley, R. Bright and D.W. Parsons

Conference Name

Abstract

Genetic therapies for cystic fibrosis (CF) must be assessed for safety and efficacy, so testing in a non-human primate (NHP) model is invaluable. In this pilot study we determined if the conducting airways of marmosets (n 5 2) could be transduced using an airway pre-treatment followed by an intratracheal bolus dose of a VSV-G pseudotyped HIV-1 based lentiviral (LV) vector (LacZ reporter). LacZ gene expression (X-gal) was assessed after 7 days and found primarily in conducting airway epithelia as well as in alveolar regions. The LacZ gene was not detected in liver or spleen via qPCR. Vector p24 protein bio-distribution into blood was transient. Dosing was well tolerated. This preliminary study confirmed the transducibility of CF-relevant airway cell types. The marmoset is a promising NHP model for testing and translating genetic treatments for CF airway disease towards clinical trials.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/

License

Grant ID

Call number

Persistent link to this record